Atlas Trials

Advanced Non-small Cell Lung Cancer and MET Exon 14 Skipping Mutation

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Non-small Cell Lung Cancer and MET Exon 14 Skipping Mutation

RecordFirmDate
Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States (NCT06161051)Novartis Pharmaceuticals2022-10-03

Track Advanced Non-small Cell Lung Cancer and MET Exon 14 Skipping Mutation automatically

Every clearance here is in the API, with alerts when new ones post.